Mangoceuticals (MGRX) Revenue (2023 - 2026)

Mangoceuticals (MGRX) posted Revenue of $67864.0 for Q1 2026, down 28.08% sequentially from $94360.0 in Q4 2025, and down 37.91% YoY from $109306.0 in Q1 2025.

Mangoceuticals (MGRX) Revenue (2023 - 2026) Analysis & Trends

Mangoceuticals has reported Revenue for 4 years, with the latest figure at $67864.0 in Q1 2026.

  • Quarterly Revenue fell 37.91% year-over-year to $67864.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $414579.0 (down 18.88% YoY) and the FY2025 annual result came in at $456021.0, down 25.96% from the prior year.
  • Revenue retreated to $67864.0 in Q1 2026 per MGRX's latest filing, from $94360.0 in the prior quarter.
  • Over five years, Revenue peaked at $245160.0 in Q3 2023 and troughed at $67864.0 in Q1 2026.
  • A 4-year average of $143942.4 and a median of $133368.0 in 2024 frame the typical range for Revenue.
  • The widest YoY moves for Revenue: up 112.56% in 2024, down 56.93% in 2024.
  • Over 4 years, Revenue stood at $244374.0 in 2023, then slumped by 56.93% to $105247.0 in 2024, then declined by 10.34% to $94360.0 in 2025, then retreated by 28.08% to $67864.0 in 2026.
  • According to Business Quant data, Revenue over the past three periods registered $67864.0, $94360.0, and $84246.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Veeva Systems 39.72 Bn 32.40 Bn 662.02 Mn 882.95 Mn
2 BrightSpring Health Services 12.19 Bn 11.64 Bn 492.75 Mn 3.87 Bn
3 Healthequity 8.79 Bn 8.52 Bn 256.31 Mn 354.64 Mn
4 10x Genomics 7.31 Bn 6.76 Bn 112.50 Mn 151.04 Mn
5 Hinge Health 7.10 Bn 6.71 Bn 183.95 Mn 212.82 Mn
6 MiniMed 5.66 Bn 5.36 Bn 480.00 Mn 837.00 Mn
7 Waystar Holding 4.76 Bn 4.56 Bn 221.99 Mn 319.67 Mn
8 Doximity 4.46 Bn 3.77 Bn 132.93 Mn 156.62 Mn
9 Heartflow 3.66 Bn 3.28 Bn 53.19 Mn 64.08 Mn
10 Mangoceuticals 9.55 Mn 9.30 Mn 44,215.00 68,757.00

Historic Data

Download Data
DateValue
Jun 30, 2026 68,757.00
Mar 31, 2026 67,864.00
Dec 31, 2025 94,360.00
Sep 30, 2025 84,246.00
Jun 30, 2025 168,109.00
Mar 31, 2025 109,306.00
Dec 31, 2024 105,247.00
Sep 30, 2024 133,368.00
Jun 30, 2024 163,163.00
Mar 31, 2024 214,095.00
Dec 31, 2023 244,374.00
Sep 30, 2023 245,160.00
Jun 30, 2023 141,237.00
Mar 31, 2023 100,722.00